About Us  |   Contact Us  |   Register  | Login  |   

Follow HedgeWorld on Twitter HedgeWorld on LinkedIn






HEDGEWORLD NEWS
Search the News
Advanced News Search
HedgeWorld News by Region
United States / Americas
Europe
Asia / Australia
International
HedgeWorld News Sections
Managed Futures & Derivatives
Daily News
Regulatory/Legal
Strategies/Analysis
Technology
Opinion
People
Indexes
Other News Features
Most Popular
LexisNexis Headlines
Reuters Headlines
The HedgeWorld Blog
Alternative Advantage Daily Newsletter
RSS Service
Sign Up For Email News Alerts
Reprints



U.S. regulators on alert for marijuana company investment scams
05/16/2014 Email this story  |  Printable Version

By Sarah N. Lynch

WASHINGTON, May 16 (Reuters) - U.S. securities regulators warned investors on Friday to be careful about getting involved in stock schemes involving small marijuana-related companies.

The Securities and Exchange Commission said it has already suspended trading in five different cannabis microcap companies in the past few months.

The latest crackdown Friday was against Fusion Pharm Inc. , a Denver-based company purportedly selling cultivation systems for marijuana.

Voters in Colorado and Washington legalized the possession and use of small amounts of marijuana for recreational use in 2012. They are also among 20 different states that permit the use of medical marijuana.

The first recreational cannabis shops opened in Colorado in January.

"Given the attention that marijuana-related companies have attracted recently, we urge investors to exercise caution when looking at investments in this space," said Lori Schock, the head of the SEC's Office of Investor Education and Advocacy.

The SEC said it had decided to suspend trading in Fusion Pharm because of questions about "the accuracy of assertions" concerning its assets, revenues, financial statements, business transactions and financial condition.

No one answered the phone at the company's Denver headquarters, and e-mail inquiries were not returned.

"Recent changes in state laws concerning medical and recreational marijuana have created new opportunities for penny stock fraud," said Elisha Frank, a co-chair of the SEC enforcement division's microcap task force.

"Whenever we see incomplete or misleading disclosures, we act quickly to protect investors."

This marks the second time now since last year that securities regulators have warned about a rise in marijuana investment schemes.

In August 2013, the Financial Industry Regulatory Authority, which self-polices the brokerage industry, issued similar warnings, saying it had seen examples of classic "pump and dump" schemes and instances of firms being run by people with criminal records.

Of the five companies whose trading was recently suspended by the SEC, the agency said several were targeted for concerns about the accuracy of how they described their operations, and two of them were suspected of illegal activity, including market manipulation and unlawful sales.

The SEC in general has been ramping up its focus on enforcement in the microcap fraud space, an area considered highly risky for investors because it involves new companies with no proven track record and volatile stock prices.

The microcap market is comprised of companies with small amounts of assets and low stock prices, often with a market capitalization of less than $250 million or $300 million.

The SEC formed the microcap task force last year to target abusive practices and companies that fail to routinely publicly report their financial results. (Reporting by Sarah N. Lynch; editing by Andrew Hay)


Email This Story to a Friend   |   Display Printable Version of This Story

Story Copyright © 1999-2014 Reuters HedgeWorld All rights reserved.

HedgeWorld News is sponsored by:






Lipper    Privacy   User Policy  Legal Disclosure Copyright/DMCA  Site Map    FAQ    Glossary  Thomson Reuters for Hedge Funds
All rights reserved. Users may download and print extracts of content from this website for their own personal and non-commercial use only. Republication or redistribution of HedgeWorld content, including by framing or similar means, is expressly prohibited without the prior written consent of Thomson Reuters. HedgeWorld is a registered trademark of Thomson Reuters.